MRPS34
Basic information
Region (hg38): 16:1771890-1773150
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 32 (Strong), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 32 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 28777931 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Combined oxidative phosphorylation deficiency 32 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRPS34 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 29 | ||||
missense | 48 | 55 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 0 | |||||
non coding | 11 | |||||
Total | 2 | 6 | 49 | 35 | 9 |
Highest pathogenic variant AF is 0.000151
Variants in MRPS34
This is a list of pathogenic ClinVar variants found in the MRPS34 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1772158-T-C | Benign (May 14, 2021) | |||
16-1772223-A-T | Uncertain significance (Dec 07, 2021) | |||
16-1772224-G-C | Likely benign (Nov 22, 2023) | |||
16-1772236-C-G | Inborn genetic diseases | Uncertain significance (Apr 26, 2023) | ||
16-1772237-T-G | Inborn genetic diseases | Uncertain significance (Dec 30, 2023) | ||
16-1772241-C-T | Uncertain significance (Sep 27, 2022) | |||
16-1772243-C-G | Uncertain significance (Aug 22, 2022) | |||
16-1772250-T-C | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
16-1772253-C-G | Inborn genetic diseases | Uncertain significance (Jan 17, 2023) | ||
16-1772258-T-A | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
16-1772280-G-A | Inborn genetic diseases | Uncertain significance (May 02, 2023) | ||
16-1772291-A-T | Uncertain significance (Sep 27, 2022) | |||
16-1772293-C-T | Benign/Likely benign (Dec 22, 2023) | |||
16-1772300-A-G | Inborn genetic diseases | Uncertain significance (Jan 24, 2023) | ||
16-1772302-A-T | Likely benign (Jul 10, 2023) | |||
16-1772307-G-A | Likely benign (May 22, 2023) | |||
16-1772314-C-T | Likely benign (Jun 27, 2022) | |||
16-1772316-C-T | Combined oxidative phosphorylation deficiency 32 | Likely pathogenic (Jan 04, 2022) | ||
16-1772346-G-A | Combined oxidative phosphorylation deficiency 32 | Likely pathogenic (Feb 18, 2022) | ||
16-1772353-G-A | Likely benign (May 16, 2023) | |||
16-1772359-C-G | Uncertain significance (May 08, 2023) | |||
16-1772362-G-A | Likely benign (May 08, 2023) | |||
16-1772364-C-T | Inborn genetic diseases | Uncertain significance (Aug 09, 2021) | ||
16-1772365-C-T | MRPS34-related disorder | Likely benign (Dec 28, 2023) | ||
16-1772371-G-A | Benign/Likely benign (Nov 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRPS34 | protein_coding | protein_coding | ENST00000397375 | 3 | 1266 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00264 | 0.576 | 124955 | 0 | 7 | 124962 | 0.0000280 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.43 | 135 | 95.7 | 1.41 | 0.00000463 | 1345 |
Missense in Polyphen | 49 | 37.535 | 1.3054 | 545 | ||
Synonymous | -1.76 | 55 | 40.7 | 1.35 | 0.00000210 | 446 |
Loss of Function | 0.333 | 4 | 4.79 | 0.836 | 2.06e-7 | 68 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000549 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000358 | 0.0000355 |
Middle Eastern | 0.0000549 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for mitochondrial translation, plays a role in maintaining the stability of the small ribosomal subunit and the 12S rRNA that are required for mitoribosome formation. {ECO:0000269|PubMed:28777931}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 32 (COXPD32) [MIM:617664]: An autosomal recessive disorder due to deficiency of mitochondrial respiratory chain complexes, I, III and IV, and characterized by delayed psychomotor development and neurodevelopmental regression. Additional variable symptoms include poor or absent speech, inability to walk, and abnormal movements. {ECO:0000269|PubMed:28777931}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.245
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- Y
- hipred_score
- 0.562
- ghis
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Mrps34
- Phenotype
- liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- mitochondrial translation;mitochondrial translational elongation;mitochondrial translational termination
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial small ribosomal subunit
- Molecular function
- structural constituent of ribosome